Event

Kisaco Pharma & Biotech Patent Litigation North America 2024

Fish & Richardson Principals Megan Chacon, Martina Hufnal, and Robert Oakes will speak at Kisaco Pharma & Biotech Patent Litigation North America on October 29 and 30, 2024. Chacon will also serve as co-chair of the event.

Fish is proud to sponsor the Kisaco Pharma & Biotech Patent Litigation North America 2024, which connects senior decision markers, policy makers, judicial representatives, and legal experts from across the U.S. and worldwide to examine the latest prosecuting and defense strategies, risk mitigation strategies, and cost-effective methods for implementing a comprehensive trade secret protection framework. Panel details are below.

Regulatory Exclusivity Overview and Its Interplay With IP Exclusivity for the Life Sciences Industry
Tuesday, October 29 | 1:15-2:00 p.m. ET

Regulatory exclusivity remains a critical factor in the life sciences market, shaping the competitive landscape and influencing market entry strategies. This session will provide an in-depth examination of the various forms of regulatory exclusivity, how they impact market dynamics, and what strategic considerations companies must navigate to maximize their market position. Attendees will gain a comprehensive understanding of how regulatory exclusivity can be leveraged or challenged, and what the future may hold for exclusivity in the evolving pharma and biotech field.

Understand different types of regulatory exclusivity (e.g., data exclusivity, orphan drug exclusivity, pediatric exclusivity) and their implications.

  • Discover case studies highlighting how exclusivity periods have impacted market entry for biosimilars.
  • Determine strategic considerations for innovators to extend exclusivity periods.
  • Learn insights into potential legislative changes and their impact on regulatory exclusivity.
  • Gain an analysis of global differences in regulatory exclusivity frameworks and their effects on multinational strategies.
  • Evaluate the impact of the IRA on coordination and discovery processes in litigation.
  • Discover how the IRA can incentivize the settlement of infringement litigation.
  • Explore practical strategies to protect the value of your IP when your drug is selected for negotiation.

Speakers:

  • Robert Oakes, Principal, Fish & Richardson
  • Raymond Parker III, Senior Patent Counsel, BioNTech
  • Sesha Kumar, Vice President & Head – Intellectual Property, Innovation, Dr. Reddy’s Laboratories

Obviousness-Type Double Patenting: Challenges in Protecting Patents Post In re Cellect
Tuesday, October 29 | 3:00-3:45 p.m. ET

Obviousness-type double patenting (OTDP) aims to prevent the issuance of multiple patents for the same invention, particularly when a second patent would be considered obvious in light of the claims in the first patent and the existing prior art. The recent In re Cellect (2024) ruling has introduced significant considerations for OTDP, especially regarding patent term extension (PTE) versus patent term adjustment (PTA). This industry session will outline the consequences of this decision for your life science IP strategy.

  • Discover how to differentiate OTDP patents in a PTA and PTE context.
  • Understand the benefits for the patent challenger after this ruling.

Speakers:

  • Martina Hufnal, Principal, Fish & Richardson
  • Bart Newland, General Counsel, Atalanta Therapeutics

Views From the Bench: Integrating a Judicial Perspective Into Your Litigation Strategy
Wednesday, October 30 | 1:15-2:15 p.m. ET

Gain unique insights from distinguished jurists overseeing some of the most dynamic Life Sciences Litigation dockets nationwide. Explore the decision-making processes employed by the judiciary and receive expert advice tailored for both prosecution and defense attorneys. These judges will illuminate common challenges in resolving complex disputes and offer invaluable insights to navigate your patent litigation challenges effectively.

Chair:

  • Megan Chacon, Principal, Fish & Richardson

Speakers:

  • The Honorable Mitchell S. Goldberg, Chief Judge, U.S. District Court for the Eastern District of Pennsylvania
  • Jacqueline Bonilla, Deputy Chief Administrative Patent Judge & Senior Legal Advisor, U.S. Patent Trial and Appeal Board
  • The Honorable Paul R. Michel (Ret.), Former Chief Judge, U.S. Court of Appeals for the Federal Circuit

For more information, or to register, click here.